When was Diagnostica Stago founded?

Diagnostica Stago was founded in 1998.

Where is Diagnostica Stago located?

Diagnostica Stago is headquartered in Paris, France.

How many employees does Diagnostica Stago have?

As of Aug 31, 2026, the latest employee count at Diagnostica Stago is 2045.

Where does Diagnostica Stago rank among its competitors?

Diagnostica Stago ranks 1st amongst 30 active competitors, of which 8 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was MedicQuant ApS, which secured $81.9K in Jul, 2023.

Who are the top competitors of Diagnostica Stago?

Diagnostica Stago's top competitors include Coag-Sense, Accriva Diagnostics and Entegrion. Among them, MedicQuant ApS secured the most recent funding round in July, 2023.

Diagnostica Stago - 2026 Company Profile & Competitors

Company Details

Stago International manufactures a broad spectrum of tests, instruments, software solutions and reagents for in vitro medical devices in the haemostasis and coagulation industry.Its products include Factor assays, Anticoagulants, Control plasmas, Calibrators, Quality and compliance solutions, Screening tests, Products to assess thrombophilia, fibrin formation and degradation, fibrinolysis, and primary hemostasis. Qualiris is a dedicated hemostasis proficiency testing program. Qualiris programs include routine (PT, APTT, Fibrinogen, Thrombin Time) hemostasis tests and a wide variety of specialty tests including D-Dimer, unfractionated heparin, low molecular weight heparin, Factor Assays, and Thrombophilia.

Website: www.stago.com/
Social

Key Metrics

Founded Year

1998

Location

Paris, France

Stage

Acquired

Ranked

1^st among 30 active competitors

Employee Count

2,045 as on Aug 31, 2026

Investment & Acquisitions

Hemosonics

Similar Companies

Coag-Sense & 32 more

Exit Details

Acquired by ARCHIMED (Apr 29, 2026)

View Diagnostica Stago's full profile

Diagnostica Stago got acquired by ARCHIMED and CDPQ on Apr 29, 2026.

Click here to take a look at Diagnostica Stago's acquisition in detail

Diagnostica Stago has not raised any funding rounds yet.

Diagnostica Stago's employee count trend

Diagnostica Stago has 2,045 employees as of Aug 26. Here is Diagnostica Stago's employee count trend over the years:

Employee count trend for Diagnostica Stago

Uncover Diagnostica Stago's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diagnostica Stago include Coag-Sense, Accriva Diagnostics and Entegrion. Here is the list of Top 10 competitors of Diagnostica Stago, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Diagnostica Stago 1998, Paris (France), Acquired	Portfolio of products for hematology and hemostasis	-	-	55/100
2nd	Coag-Sense 2008, San Francisco (United States), Series A	Innovating coagulation monitoring with accurate, accessible PT/INR testing solutions	$5M	DSC Investment, Korea Investment Holdings ... & 1 others	49/100
3rd	Accriva Diagnostics 2009, San Diego (United States), Acquired	Develop products/systems for diagnostics.	$144M	Kleiner Perkins, Bay City Capital & 3 others	47/100
4th	Entegrion 2002, Durham (United States), Series B	Provider of hemostasis and fluid replacement products	$30.5M	Sway Ventures, Defense.gov & 4 others	43/100
5th	Enzyre 2016, Nijmegen (Netherlands), Series A	Developer of smart diagnostics devices for blood coagulation analysis	$11.9M	Oost NL, Novalis Biotech & 3 others	40/100
6th	Medical Ingenuities 2011, Wheaton (United States), Series A	Developer of radial artery occlusion devices for hematology treatments	$997K	cultivate(MD), Genesis & 3 others	35/100
7th	Perosphere 2011, Mount Kisco (United States), Acquired	Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.	$9.36M	Connecticut Innovations	34/100
8th	MedicQuant ApS 2019, Aarhus (Denmark), Seed	Provider of diagnostic kit for blood anticoagulants	-	Waarst Holding, BioInnovation Institute & 2 others	34/100
9th	16•12 2005, Pordenone (Italy), Seed	Provider of a diagnostic device to evaluate the patient's hemorrhagic and thrombotic potential	$900K	Italian Angels for Growth, Europa	33/100
10th	ClotPro 2017, Munich (Germany), Acquired	Provider of device for coagulation diagnostic	-	-	32/100